Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brizzi ME"'
Autor:
López-Sundh AE; Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Escribano-Palomino E; Department of Neonatology, Hospital Universitario La Paz, Madrid, Spain., Feito-Rodríguez M; Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain., Tenorio J; CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.; Institute of Medical and Molecular Genetics (INGEMM)-IdiPAZ, Hospital Universitario La Paz-UAMs, Madrid, Spain.; ITHACA, European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability, Paris, France., Brizzi ME; Department of Pathology, Hospital Universitario La Paz, Madrid, Spain., Krasnovska Zayets K; Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain., Servera-Negra G; Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain., de Lucas-Laguna R; Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain.
Publikováno v:
American journal of medical genetics. Part A [Am J Med Genet A] 2023 Jan; Vol. 191 (1), pp. 253-258. Date of Electronic Publication: 2022 Oct 26.
Autor:
López-Janeiro Á; Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Villalba-Esparza M; Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Brizzi ME; Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Jiménez-Sánchez D; Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Ruz-Caracuel I; Department of Pathology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain., Kadioglu E; Lunaphore Technologies SA, Tolochenaz, Switzerland., Masetto I; Akoya Biosciences, Marlborough, MA, USA., Goubert V; Akoya Biosciences, Marlborough, MA, USA., Garcia-Ros D; Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Melero I; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain., Peláez-García A; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), Madrid, Spain., Hardisson D; Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., de Andrea CE; Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
The Journal of pathology [J Pathol] 2022 Dec; Vol. 258 (4), pp. 426-436. Date of Electronic Publication: 2022 Oct 25.